SCHEMBL9687045

SCHEMBL9687045

CCc1ccc(Cc2ccnc(N)c2N)o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 5/20 0.39
NOS3 P29474 4/20 0.39
TLR8 Q9NR97 2/20 0.38
CYP1A2 P05177 1/20 0.33
CYP2E1 P05181 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9686545 0.84 MAPT (0.49) NOS2NOS3TLR8CYP2C9ALDH1A1
SCHEMBL9686463 0.81 NOS3 (0.37) NOS2NOS3TLR8ALDH1A1POLB
SCHEMBL3264472 0.77 NOS2 (0.52) NOS2NOS3TLR8CYP2E1CYP2C8
SCHEMBL4986132 0.76 NOS2 (0.42) NOS2NOS3TLR8ALDH1A1POLB
SCHEMBL9387184 0.73 GAA (0.40) NOS2NOS3CYP1A2CYP2D6ALDH1A1
SCHEMBL9686513 0.72 NOS2 (0.41) NOS2NOS3TLR8NOS1
SCHEMBL5727136 0.71 DHFR (0.40)
SCHEMBL5727129 0.71 DHFR (0.40)
SCHEMBL4987971 0.70 NOS2 (0.42) NOS2NOS3TLR8NOS1
SCHEMBL6031149 0.70 NOS2 (0.53) NOS2NOS3TLR8CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0295742-B1 NOVEL N-(4-PIPERIDINYL) BICYCLIC CONDENSED 2-IMIDAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-26 EP disclosed
EP-0295742-A1 Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-21 EP disclosed